12 resultaten
Both interventions (GRAIL training & endurance and strength training (control intervention)) will result in an increase in gait speed, functional walking ability and social participation. However, the GRAIL training will result in larger…
There might be discrepancies in number and type of Cancer Predisposition Syndrome diagnoses between the genotype first and the phenotype first approach.
REE zal gemeten worden middels indirecte calorimetrie. Zuurstofverbruik (VO2) en koolstofdioxide productie (VCO2) worden gemeten. De respiratoire quotient (RQ) zal verkregen worden uit de VO2 e n VCO2. Lichaamssamenstelling zal…
Primair: Bepalen van de verandering in albumine:creatinine ratio in eerste ochtendurine van begin tot eind van de behandeling. Secundair: Bepalen van veranderingen ten opzichte van baseline in: - Systolische bloeddruk - Lichaamsgewicht…
The new treatment algorithm for patients with high-risk T1b EAC consisting of radical ER of the tumor, followed by a sentinel node procedure with selective lymphadenectomy is feasible and safe.
Primaire doelen: 1. de uitvoerbaarheid van FMT bij patiënten met de zvP beoordelen 2. de veiligheid van FMT bij patiënten met de zvP beoordelen. Secundaire doelen: 1. Bepalen of FMT op lange termijn (tot 12 maanden na FMT) leidt tot…
Onderzoeken wat de diagnostische nauwkeurigheid is van echografie voor het uitsluiten (of aantonen) van elleboogfracturen bij volwassenen ten opzichte van de gouden standaard röntgendiagnostiek.
Subjects with a divergent PGx phenotype experience more side effects and/or reduced drug efficacy compared to those with a PGx phenotype in normal range.
We hypothesize that the risk of any congenital abnormality in fetuses with an early increased NT that normalizes, will be lower than those with persistent increased NT after 11 weeks of gestation.
Tumor-positive lymph nodes in patients with early EAC can be accurately detected through a sentinel node procedure.
Active surveillance is non-inferior to surgery in patients with oesophageal cancer showing complete clinical response after neoadjuvant chemoradiotherapy.